Recent advances in nano/biotechnology have led to remarkable successes in biomedical applications. Our research team, bringing together expertise in chemistry, bioengineering, pharmacy, and medicine, is committed to harnessing cutting-edge technologies to address intractable diseases such as cancer, rheumatoid arthritis, liver fibrosis, and atherosclerosis. For instance, in pursuit of precision and personalized medicine, we are focusing on advances in nanomedicine, biomedicine and diagnostic platforms.